Navigation Links
Plasma nanoscience needed for green energy revolution

A step change in research relating to plasma nanoscience is needed for the world to overcome the challenge of sufficient energy creation and storage, says a leading scientist from CSIRO Materials Science and Engineering and the University of Sydney, Australia.

Professor Kostya (Ken) Ostrikov of the Plasma Nanoscience Centre Australia, CSIRO Materials Science and Engineering, has highlighted, in IOP Publishing's Journal of Physics D: Applied Physics, the unique potential of plasma nanoscience to control energy and matter at fundamental levels to produce cost-effective, environmentally and human health friendly nanoscale materials for applications in virtually any area of human activity.

Professor Ostrikov is a pioneer in the field of plasma nanoscience, and was awarded the Australian Future Fellowship (2011) of the Australian Research Council, Walter Boas Medal of the Australian Institute of Physics (2010), Pawsey Medal of the Australian Academy of Sciences (2008), and CEO Science Leader Fellowship and Award of CSIRO (2008) on top of gaining seven other prestigious fellowships and eight honorary and visiting professorships in six different countries.

He said: "We can find the best, most suitable plasmas and processes for virtually any application-specific nanomaterials using plasma nanoscience knowledge.

"The terms 'best' and 'most-suitable' have many dimensions including quality, yield, cost, environment and human friendliness, and most recently, energy efficiency."

Plasma nanoscience involves the use of plasma an ionised gas at temperatures from just a few to tens of thousands Kelvin as a tool to create and process very small (nano) materials for use in energy conversion, electronics, IT, health care, and numerous other applications that are critical for a sustainable future.

In particular, Ostrikov points out the ability of plasma to synthesise carbon nanotubes one of the most exciting materials in modern physics, with extraordinary properties arising from their size, dimension, and structure, capable of revolutionising the way energy is produced, transferred and stored.

Until recently, the unpredictable nature of plasma caused some scientists to question its ability to control energy and matter in order to construct nanomaterials, however Ostrikov draws on existing research to provide evidence that it can be controlled down to fundamental levels leading to cost-effective and environmentally friendly processes.

Compared to existing methods of nanomaterials production, Ostrikov states that plasma can offer a simple, cheaper, faster, and more energy efficient way of moving "from controlled complexity to practical simplicity" and has encouraged researchers to grasp the opportunities that present themselves in this field.


Contact: Joe Winters
Institute of Physics

Related biology technology :

1. PEAK Surgical Introduces PlasmaBlade(TM) Product Line Extensions for Use in General Surgery
2. Octapharma Names Dennis D. Curtin To Lead U.S. Plasma Operations
3. New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers
4. Researchers prolong the plasma half-life of biopharmaceutical proteins
5. Norgen Biotek Launches 10 New Kits for the Isolation of High-Quality Circulating Nucleic Acids from Blood, Plasma and Serum
6. Painless plasma jets could replace dentists drill
7. Ruedi Waeger Receives the 2010 Robert W. Reilly Leadership Award from Plasma Protein Therapeutics Association
8. PPTA Urges CMS for Appropriate Hospital Outpatient Reimbursement for Plasma Protein Therapies
9. First Duplex Test for Parvovirus B19 and Hepatitis A Virus Increases Safety of Human Plasma and Plasma Products
10. Plasma Protein Therapies Not Suitable for Biosimilars
11. New Video on Plasma Donation Available
Post Your Comments:
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica ... in people with peritoneal or pleural mesothelioma. Their findings are the subject of a ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of ...
(Date:6/23/2016)... ... 2016 , ... UAS LifeSciences, one of the leading manufacturers ... Probiotics, into Target stores nationwide. The company, which has been manufacturing high quality ... list of well-respected retailers. This list includes such fine stores as Whole Foods, ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology:
(Date:6/9/2016)... June 9, 2016 Paris ... Teleste,s video security solution to ensure the safety of people ... during the major tournament Teleste, an international ... and services, announced today that its video security solution will ... to back up public safety across the country. The system ...
(Date:6/2/2016)... June 2, 2016 Perimeter Surveillance ... Unmanned Systems, Physical Infrastructure, Support & Other Service  ... visiongain offers comprehensive analysis of the global ... will generate revenues of $17.98 billion in 2016. ... Inc, a leader in software and hardware technologies for ...
(Date:5/12/2016)... May 12, 2016 , a ... the overview results from the Q1 wave of its ... wave was consumers, receptivity to a program where they ... a health insurance company. "We were surprised ... says Michael LaColla , CEO of Troubadour Research, ...
Breaking Biology News(10 mins):